Efficacy and safety of 180W laser photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia with a report experience of 433 cases
Wang Linchun, Peng Zhufeng△, Zhou Jing, Song Pan, Yang Luchen, Liu Zhenghuan, Chen Junhao, Ma Kai, Liu Liangren, Dong Qiang*
Department of Urology, West China Hospital, Sichuan University, Chengdu 610041, China
Abstract：Objective： To evaluate the clinical efficacy and safety of 180W greenlight laser photoselective vaporization of the prostate （PVP） in the treatment of benign prostatic hyperplasia （BPH）. Methods： A retrospective analysis was performed on the patients who underwent 180 W greenlight laser PVP between June 2018 and December 2020. The patients’ data including preoperative data, indicators during hospitalization, postoperative complications and follow-up information were collected. Results： A total of 433 patients were included with a age of （69.6±8.7）years. Preoperative prostate volume was （68.8±28.5）ml. The operation time was （53.2±23.8）min. The mean bladder irrigation time was （17.3±3.2）h and mean catheterization time was （23.3±6.8）h. With a mean postoperative hospital stay of （1.6±1.0） days, the rate of postoperative urinary retention, retrograde ejaculation and urethral stricture was 5.3%, 0.9% and 0.9%, respectively. No patient had blood transfusion, unplanned reoperation or death. The International Prostate Symptom Score （IPSS） of patients decreased significantly from （21.1±3.3） at baseline to （9.5±3.7） at 1month, （77.0±3.3） at 3 months, （6.9±2.3） at 6 months and （7.1±2.5） at 12 months. Meanwhile, the quality of life （QOL） score was also significantly reduced from （4.9±0.6） at baseline to （2.9±0.7） at 1 month, （1.8±0.9） at 3 months, （1.8±0.9） at 6 months and （1.8±0.6） at 12 months. Conclusion： 180W green laser PVP for the treatments of BPH is safe and effective with the advantages of less bleeding, quicker postoperative recovery and fewer complications.
王临春, 彭珠峰, 周敬, 宋攀, 杨璐辰, 刘正欢, 陈俊豪, 马凯, 柳良仁, 董强. 180W 绿激光前列腺汽化术治疗良性前列腺增生的疗效和安全性（附433例报道）[J]. 微创泌尿外科杂志, 2022, 11(1): 24-27.
Wang Linchun, Peng Zhufeng, Zhou Jing, Song Pan, Yang Luchen, Liu Zhenghuan, Chen Junhao, Ma Kai, Liu Liangren, Dong Qiang. Efficacy and safety of 180W laser photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia with a report experience of 433 cases. JOURNAL OF MINIMALLY INVASIVE UROLOGY, 2022, 11(1): 24-27.
[1] WANG W, GUO Y, ZHANG D, et al. The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys[J]. Sci Rep,2015,5(1):13546. [2] PARSONS JK, BARRY MJ, DAHM P, et al. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline[J]. J Urol,2018,200(3):612-619. [3] REICH O, GRATZKE C, BACHMANN A, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients[J]. J Urol,2008,180(1):246-249. [4] TE AE. The next generation in laser treatments and the role of the GreenLight high-performance system laser[J]. Rev Urol,2006,8(Suppl 3):S24-S30. [5] HERMANNS T, STREBEL DD, HEFERMEHL LJ, et al. Lithium triborate laser vaporization of the prostate using the 120 W, high performance system laser: high performance all the way?[J] J Urol,2011,185(6):2241-2247. [6] BRUNKEN C, MUNSCH M, TAUBER S, et al. The 532-nm 180-W (GreenLight®) laser vaporization of the prostate for the treatment of lower urinary tract symptoms: how durable is the new side-fire fiber with integrated cooling system?[J] Lasers Med Sci,2014,29(3):1307-1312. [7] BARRY MJ. Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia[J]. Urology,2001,58(6 Suppl 1):25-32; discussion 32. [8] LAI S, PENG P, DIAO T, et al. Comparison of photoselective green light laser vaporisation versus traditional transurethral resection for benign prostate hyperplasia: an updated systematic review and meta-analysis of randomised controlled trials and prospective studies[J]. BMJ Open, 2019,9(8):e028855. [9] BEN-ZVI T, HUEBER P A, LIBERMAN D, et al. GreenLight XPS 180W vs HPS 120W laser therapy for benign prostate hyperplasia:a prospective comparative analysis after 200 cases in a single-center study[J]. Urology,2013,81(4):853-858. [10] 童臻,迟辰斐,施安,等.120 W和180 W光选择性前列腺汽化术对于80g以上腺体的高危前列腺增生患者的疗效比较[J].现代泌尿外科杂志,2017,22(2):100-103. [11] 方琨,杨博,屈锐,等.120W绿激光前列腺汽化术在不同BPH患者群体间的疗效及安全性分析[J].中华男科学杂志,2015,21(7):619-625. [12] 曹万里,阴雷,琚官群,等.180W XPS绿激光经尿道前列腺汽化术治疗良性前列腺增生的临床应用体会[J].临床泌尿外科杂志,2018,33(4):265-268.
